LPC
PRAX icon

Lion Point Capital’s Praxis Precision Medicines PRAX Stock Holding History

Lion Point Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Hold
4,450
– – 7.13% 2
2026
Q1 		$1.43M Hold
4,450
– – 8.57% 1
2025
Q4 		$1.31M Sell
4,450
-1,250
-22% -$233K 6.79% 2
2025
Q3 		$302K Buy
+5,700
New +$276K 1.72% 22

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Lion Point Capital's PRAX Position: Q2 2026 in Review

Lion Point Capital held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 4,450 shares worth $1.49M. The position accounts for 7.13% of the portfolio, ranked #2.

Lion Point Capital first reported a position in PRAX in Q3 2025 and has held it in 4 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Lion Point Capital held 4,450 shares of Praxis Precision Medicines worth $1.49M as of Q2 2026.
  • Lion Point Capital left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 7.13% of Lion Point Capital's portfolio in Q2 2026, its #2 holding.
  • Lion Point Capital first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 4 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Lion Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.